RESULTS

Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma (Cancer Rep., 2021)

In collaboration with Osaka University Graduate School of Medicine, Department of Gastroenterology (Profs Yuichiro Doki, Hidetoshi Eguchi, and Masaki Mori), Matsushita et al. studied s significant molecule in mechanical biology, Myl9, in pancreatic cancer, and demonstrated its importance as both biomarker and therapeutic target.